Interaction between the AAA+ ATPase p97 and its cofactor ataxin3 in health and disease: Nucleotide-induced conformational changes regulate cofactor binding

J Biol Chem. 2017 Nov 10;292(45):18392-18407. doi: 10.1074/jbc.M117.806281. Epub 2017 Sep 22.

Abstract

p97 is an essential ATPase associated with various cellular activities (AAA+) that functions as a segregase in diverse cellular processes, including the maintenance of proteostasis. p97 interacts with different cofactors that target it to distinct pathways; an important example is the deubiquitinase ataxin3, which collaborates with p97 in endoplasmic reticulum-associated degradation. However, the molecular details of this interaction have been unclear. Here, we characterized the binding of ataxin3 to p97, showing that ataxin3 binds with low-micromolar affinity to both wild-type p97 and mutants linked to degenerative disorders known as multisystem proteinopathy 1 (MSP1); we further showed that the stoichiometry of binding is one ataxin3 molecule per p97 hexamer. We mapped the binding determinants on each protein, demonstrating that ataxin3's p97/VCP-binding motif interacts with the inter-lobe cleft in the N-domain of p97. We also probed the nucleotide dependence of this interaction, confirming that ataxin3 and p97 associate in the presence of ATP and in the absence of nucleotide, but not in the presence of ADP. Our experiments suggest that an ADP-driven downward movement of the p97 N-terminal domain dislodges ataxin3 by inducing a steric clash between the D1-domain and ataxin3's C terminus. In contrast, MSP1 mutants of p97 bind ataxin3 irrespective of their nucleotide state, indicating a failure by these mutants to translate ADP binding into a movement of the N-terminal domain. Our model provides a mechanistic explanation for how nucleotides regulate the p97-ataxin3 interaction and why atypical cofactor binding is observed with MSP1 mutants.

Keywords: ATPases associated with diverse cellular activities (AAA); ataxin3; cofactor binding; conformational change; electron microscopy (EM); multisystem proteinopathy 1 (MSP1); nucleotide regulation; p97/VCP; proteostasis; surface plasmon resonance (SPR).

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adenosine Diphosphate / chemistry
  • Adenosine Diphosphate / metabolism
  • Adenosine Triphosphate / chemistry
  • Adenosine Triphosphate / metabolism
  • Amino Acid Substitution
  • Ataxin-3 / chemistry
  • Ataxin-3 / genetics
  • Ataxin-3 / metabolism*
  • Binding Sites
  • Binding, Competitive
  • Coenzymes / chemistry
  • Coenzymes / genetics
  • Coenzymes / metabolism*
  • Crystallography, X-Ray
  • Databases, Protein
  • Distal Myopathies / enzymology
  • Distal Myopathies / genetics
  • Distal Myopathies / metabolism*
  • Humans
  • Microscopy, Electron, Transmission
  • Models, Molecular*
  • Mutation
  • Peptide Fragments / chemistry
  • Peptide Fragments / genetics
  • Peptide Fragments / metabolism
  • Protein Conformation
  • Protein Interaction Domains and Motifs
  • Protein Interaction Mapping
  • Protein Multimerization
  • Proteostasis Deficiencies / enzymology
  • Proteostasis Deficiencies / genetics
  • Proteostasis Deficiencies / metabolism*
  • Recombinant Fusion Proteins / chemistry
  • Recombinant Fusion Proteins / metabolism
  • Repressor Proteins / chemistry
  • Repressor Proteins / genetics
  • Repressor Proteins / metabolism*
  • Valosin Containing Protein / chemistry
  • Valosin Containing Protein / genetics
  • Valosin Containing Protein / metabolism*

Substances

  • Coenzymes
  • Peptide Fragments
  • Recombinant Fusion Proteins
  • Repressor Proteins
  • Adenosine Diphosphate
  • Adenosine Triphosphate
  • ATXN3 protein, human
  • Ataxin-3
  • VCP protein, human
  • Valosin Containing Protein

Supplementary concepts

  • Distal myopathy, Nonaka type

Associated data

  • PDB/3TIW
  • PDB/5FTK
  • PDB/5FTM
  • PDB/5EPP